# Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell Disease

> **NCT02447627** · — · COMPLETED · sponsor: **Bioverativ Therapeutics Inc.** · enrollment: 38 (actual)

## Conditions studied

- Healthy
- Sickle Cell Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02447627
- **Lead sponsor:** Bioverativ Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2020-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02447627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02447627, "Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell Disease". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02447627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*